Patient preference for extended palliative chemotherapy for non-small cell lung cancer
- 1 April 1995
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 345 (8953) , 857-858
- https://doi.org/10.1016/s0140-6736(95)92993-2
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancerBritish Journal of Cancer, 1995
- The MIC regimen in non-small cell lung cancerLung Cancer, 1993
- Polychemotherapy in advanced non small cell lung cancer: a meta-analysisThe Lancet, 1993
- Is chemotherapy for non-small cell lung cancer worthwhile?The Lancet, 1993
- Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer.Journal of Clinical Oncology, 1990